Staining Pattern in Normal Tissues
Manual protocol
Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121°C in pH 7,8 Target Retrieval Solution buffer. Apply HMV320 at a dilution of 1:200 at 37°C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer’s directions.
| Brain | Cerebrum, grey | Negative | |
| Cerebrum, white | Negative | ||
| Cerebellum, cortex | Negative | ||
| Cerebellum, white | Negative | ||
| Ganglion | Negative | ||
| Ependyma | Negative | ||
| Eye, retina | Negative | ||
| Endocrine Tissues | Thyroid | Weak granular cytoplasmic SDHB staining of epithelial cells. | |
| Parathyroid gland | Moderate to strong granular cytoplasmic SDHB staining of epithelial cells. Marked heterogeneity between cells and cell groups. | ||
| Adrenal gland | Strong granular cytoplasmic SDHB staining of epithelial cells. | ||
| Pituitary gland, anterior lobe | Negative | ||
| Pituitary gland, posterior lobe | Negative | ||
| Respiratory system | Lung bronchi | Negative | |
| Lung, bronchial glands | Negative | ||
| Nose, paranasal sinus | Negative | ||
| Lung, parenchyma | Negative | ||
| Proximal digestive tract | Lip | Negative | |
| Oral cavity | Negative | ||
| Tonsil, surface | Negative | ||
| Esophagus, mucosa | Negative | ||
| Lip, small salivary gland | Negative | ||
| Sublingual gland | Negative | ||
| Parotid gland | Negative | ||
| Submandibullary gland | Negative | ||
| Gastronintestinal tract | Stomach, antrum | Negative | |
| Stomach, fundus and corpus | Negative | ||
| Small intestine, duodenum | Negative | ||
| Duodenum, Brunner gland | Negative | ||
| Small intestine, ileum | Negative | ||
| Appendix | At least a moderate granular cytoplasmic SDHB staining of all cells, predominantly in the epithelium. | ||
| Colon descendens | Negative | ||
| Rectum | At least a moderate granular cytoplasmic SDHB staining of all cells, predominantly in the epithelium. | ||
| Anal canal, transition epithelium | Negative | ||
| Liver, Gallbladder, Pancreas | Liver | Substantial granular cytoplasmic SDHB staining of cells, especially in hepatocytes. | |
| Gallbladder | Significant granular cytoplasmic SDHB staining of epithelial cells, predominately in the sub-apical compartment. | ||
| Pancreas | Granular cytoplasmic SDHB staining of all epithelial cells. It is weakest in islet cells and strongest in some small excretory ducts. | ||
| Kidney, urinary bladder | Kidney, cortex | Negative | |
| Kidney, medulla | Negative | ||
| Urinary bladder, urothelium | Negative | ||
| Kidney pelvis, mucosa | Negative | ||
| Male tissues | Prostate | Rather weak granular cytoplasmic SDHB staining – somewhat stronger in epithelial than in stromal cells. | |
| Seminal vesicle | Negative | ||
| Epididymis caput | Negative | ||
| Epididymis cauda | Negative | ||
| Testis | Granular cytoplasmic SDHB staining is strongest in maturing germ cells. | ||
| Female Tissues | Breast, glands | Negative | |
| Ectocervix | Negative | ||
| Endocervix | Negative | ||
| Endometrium, proliferation | Negative | ||
| Endometrium, secretion | Negative | ||
| Uterus, myometrium | Weak granular cytoplasmic SDHB staining of muscle cells. | ||
| Fallopian tube | Weak to moderate granular cytoplasmic SDHB staining of epithelial cells. | ||
| Ovary, stroma | Negative | ||
| Ovary, follicular cyst | Negative | ||
| Ovary, corpus luteum | Negative | ||
| Amnion | Weak to moderate granular cytoplasmic SDHB staining of amnion cells. | ||
| Chorion | Weak to moderate granular cytoplasmic SDHB staining of chorion cells. | ||
| Amnion/Chorion | Negative | ||
| Placenta, early, decidua | Negative | ||
| Placenta, first trimenon | Negative | ||
| Placenta, mature | Weak granular cytoplasmic SDHB staining of throphoblast cells. | ||
| Muscle, connective & soft tissue | Aorta, intima | Negative | |
| Skeletal muscle | Weak to moderate granular cytoplasmic SDHB staining. | ||
| Aorta, media | Negative | ||
| Skeletal muscle, tongue | Negative | ||
| Heart, left ventricle | Negative | ||
| Kidney pelvis, muscular wall | Negative | ||
| Urinary bladder, muscular wall | Negative | ||
| Esophagus, muscular wall | Negative | ||
| Stomach, muscular wall | Negative | ||
| Ileum, muscular wall | Negative | ||
| Appendix, muscular wall | Negative | ||
| Colon descendens, muscular wall | Negative | ||
| Penis, glans, corpus spongiosum | Negative | ||
| Fat, white | Negative | ||
| Skin | Skin, surface | Negative | |
| Skin (hairs, sebaceous glands) | Negative | ||
| Anal canal, skin | Negative | ||
| Scrotum | Negative | ||
| Bone Marrow & lymphoid tissues | Bone marrow | Granular cytoplasmic SDHB staining is only faint, if at all visible. | |
| Thymus | Weak to moderate granular cytoplasmic SDHB staining of lymphocytes. | ||
| Spleen | Faint granular cytoplasmic SDHB staining of a fraction of inflammatory cells. | ||
| Lymph node | Weak to moderate granular cytoplasmic SDHB staining of lymphocytes. | ||
| Tonsil, deep | Negative |
Details
More product details
More product details
Biology behind
Succinate dehydrogenase complex iron sulfur subunit B (SDHB) is a 31.6 kDa protein coded by the SDHB gene at chromosome 1p36.1-p35. SDHB forms the succinate dehydrogenase protein complex II together with SDHA, SDHC and SDHD. Within this complex, SDHB is linked to SDHA at the catalytic end of the SDH protein complex which protrudes into the mitochondrial matrix while SDHC and SDHD are hydrophobic and attach the SDH complex to the inner mitochondrial membrane. SDH plays a pivotal role in both the citric acid cycle and the respiratory chain. It catalyzes the conversion of succinate to fumarate in the citric acid cycle downstream of IDH2. A loss of enzyme activity results in accumulation of metabolic intermediates similarly as under hypoxic conditions. Such a “pseudohypoxia” results in HIF-1 pathway activation and may induce a metabolic shift toward aerobic glycolysis. SDHB germline mutations can cause pheochromocytoma, paraganglioma, gastrointestinal stromal tumor (GIST), and renal cell carcinoma. Paragangliomas with SDHB mutations are often malignant. SDHB immunohistochemistry is a surrogate tool for assessing the entire SDH complex (SDHA, SDHB, SDHC, SDHD) including the activity of its assembling factor SDHAF2. If any of these components is lost, the entire SDH complex either becomes unstable or does not form. As a result SDHB is released into the cytoplasm where it degrades rapidly. This loss of expression of SDHB can be detected by IHC.
Protocol Recommendations
Protocol Recommendations
Potential Research Applications
Potential Research Applications
Evidence For Antibody Specificity In I H C
Evidence For Antibody Specificity In I H C













